Literature DB >> 12750700

Cryptic insertion and translocation or nondividing leukemic cells disclosed by FISH analysis in infant acute leukemia with discrepant molecular and cytogenetic findings.

N Watanabe1, H Kobayashi, O Ichiji, M A Yoshida, A Kikuta, Y Komada, I Sekine, Y Ishida, Y Horiukoshi, Y Tsunematsu, M Yano, H Nakadate, Y Kaneko.   

Abstract

Of 51 infants with acute leukemia, 13 (25%) had contradictory findings on 11q23/MLL rearrangements that were analyzed by cytogenetic and Southern blot methods: seven had rearranged MLL and normal karyotype, four had rearranged MLL and abnormal karyotype with no 11q23 translocation, and two had germline MLL and 11q23 translocations. Fluorescent in situ hybridization (FISH) analysis using an MLL probe that was performed to elucidate the discrepancy disclosed the presence of normal dividing cells and nondividing leukemic cells in the same bone marrow in five patients, and cryptic insertion or translocation in another five. Subsequent FISH and reverse transcription-polymerase chain reaction analysis identified the MLL-AF10, MLL-AF4, or MLL-AF1q fusions that were produced by the cryptic rearrangements in four of the five patients. In the remaining three patients, the breakpoint of 11q23 translocation was located distal to the MLL locus in one, and the discrepancy was unresolved in two. Thus, FISH should complement cytogenetic analysis when cytogenetic and molecular genetic findings are contradictory in infant leukemia, and when infant leukemia does not show 11q23 translocations or other specific translocations including t(7;12), t(1;22), etc that are recurrently found in infant leukemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12750700     DOI: 10.1038/sj.leu.2402900

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  4 in total

1.  Gene mining: a novel and powerful ensemble decision approach to hunting for disease genes using microarray expression profiling.

Authors:  Xia Li; Shaoqi Rao; Yadong Wang; Binsheng Gong
Journal:  Nucleic Acids Res       Date:  2004-05-17       Impact factor: 16.971

2.  MLL/AF-1p fusion in therapy-related early pre-B acute lymphoblastic leukemia with t(1;11)(p32;q23) translocation developing in the relapse phase of acute promyelocytic leukemia.

Authors:  Takayuki Tsujioka; Hideho Wada; Shunji Yamamori; Takemi Otsuki; Sinichiro Suemori; Toshinori Kondo; Hidekazu Nakanishi; Yoshimasa Suetsugu; Makoto Mikami; Takashi Sugihara
Journal:  Int J Hematol       Date:  2003-12       Impact factor: 2.490

3.  Identification of Mixed Lineage Leukemia Gene (MLL)/MLLT10 Fusion Transcripts by Reverse Transcription-PCR and Sequencing in a Case of AML With a FISH-Negative Cryptic MLL Rearrangement.

Authors:  Kiwoong Ko; Min-Jung Kwon; Hee-Yeon Woo; Hyosoon Park; Chang-Hun Park; Seung-Tae Lee; Sun-Hee Kim
Journal:  Ann Lab Med       Date:  2015-05-21       Impact factor: 3.464

4.  Involvement of AF1q/MLLT11 in the progression of ovarian cancer.

Authors:  Paola Tiberio; Ludmila Lozneanu; Valentina Angeloni; Elena Cavadini; Patrizia Pinciroli; Maurizio Callari; Maria Luisa Carcangiu; Domenica Lorusso; Francesco Raspagliesi; Valentina Pala; Maria Grazia Daidone; Valentina Appierto
Journal:  Oncotarget       Date:  2017-04-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.